PKI-tide

CAS No. 126370-52-3

PKI-tide( ——— )

Catalog No. M40347 CAS No. 126370-52-3

PKItide exhibits an IC50 of 0.2 μM for cAMP-PK.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PKI-tide
  • Note
    Research use only, not for human use.
  • Brief Description
    PKItide exhibits an IC50 of 0.2 μM for cAMP-PK.
  • Description
    PKItide exhibits an IC50 of 0.2 μM for cAMP-PK.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    IC50: 0.2 μM (cAMP-PK).
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    126370-52-3
  • Formula Weight
    1989.29
  • Molecular Formula
    C85H149N31O24
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Specificities of autoinhibitory domain peptides for four protein kinases. Implications for intact cell studies of protein kinase function. J Biol Chem. 1990 Feb 5;265(4):1837-40.?
molnova catalog
related products
  • Decyl-TPP bromide

    Decyl-TPP bromide may be used as an intermediate for chemical synthesis and an inactive control or as a reference to mitoquinone (MitoQ).

  • Sultiame

    Sultiame is an inhibitor of carbonic anhydrase. Sultiame can be used in antiepileptic research.

  • Tibesaikosaponin V

    Tibesaikosaponin V (TKV) is a triterpene diglycoside, which can be isolated from the methanol extract of the roots of Bupleurum chinense DC.. Tibesaikosaponin V inhibits lipid accumulation and triacylglycerol content occurred without cytotoxicity to adipocytes. Tibesaikosaponin V suppresses the mRNA expression of nuclear transcription factors, such as peroxisome proliferator-activated receptor γ (PPARγ) and CCAAT/enhancer binding protein α (C/EBPα). Tibesaikosaponin V inhibits 3T3-L1 preadipocyte differentiation. Tibesaikosaponin V can be used fro research of obesity and its associated metabolic disorders.